BR112013010325A2 - composições para o tratamento de úlceras periféricas de várias origens - Google Patents

composições para o tratamento de úlceras periféricas de várias origens

Info

Publication number
BR112013010325A2
BR112013010325A2 BR112013010325A BR112013010325A BR112013010325A2 BR 112013010325 A2 BR112013010325 A2 BR 112013010325A2 BR 112013010325 A BR112013010325 A BR 112013010325A BR 112013010325 A BR112013010325 A BR 112013010325A BR 112013010325 A2 BR112013010325 A2 BR 112013010325A2
Authority
BR
Brazil
Prior art keywords
ulcers
compositions
various origins
treating peripheral
peripheral ulcers
Prior art date
Application number
BR112013010325A
Other languages
English (en)
Inventor
Ezio Bombardelli
Massimo Ronchi
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43738126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013010325(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of BR112013010325A2 publication Critical patent/BR112013010325A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

composições para o tratamento de úlceras periféricas de várias origens. a presente invenção refere-se a composições que contêm uma combinação de um agente estimulante de proliferação das células com propriedades vasocinéticas e um agente antimicrobiano, antifúngico, antiviral com um anti-inflamátorio/analg[esico, que é últil no tratamento de úlceras periféricas de diversas origens, tais como úlceras diabéticas, úlceras causadas por meio da estase venosa dos membros, escaras e as infecções associadas á pele. a referida combinação pode ser apresentada como formulações para utilização tópica ou sistêmica.
BR112013010325A 2010-10-28 2011-10-21 composições para o tratamento de úlceras periféricas de várias origens BR112013010325A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A002009A IT1402749B1 (it) 2010-10-28 2010-10-28 Composizioni per il trattamento di ulcere periferiche di varia origine
PCT/EP2011/068399 WO2012055774A1 (en) 2010-10-28 2011-10-21 Compositions for the treatment of peripheral ulcers of various origins

Publications (1)

Publication Number Publication Date
BR112013010325A2 true BR112013010325A2 (pt) 2016-09-20

Family

ID=43738126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013010325A BR112013010325A2 (pt) 2010-10-28 2011-10-21 composições para o tratamento de úlceras periféricas de várias origens

Country Status (21)

Country Link
US (1) US9770475B2 (pt)
EP (1) EP2632475B1 (pt)
JP (1) JP6060084B2 (pt)
KR (1) KR101861347B1 (pt)
CN (1) CN103189066A (pt)
AR (1) AR083594A1 (pt)
AU (1) AU2011322734B2 (pt)
BR (1) BR112013010325A2 (pt)
CA (1) CA2816185C (pt)
DK (1) DK2632475T3 (pt)
ES (1) ES2606141T3 (pt)
HU (1) HUE032121T2 (pt)
IL (1) IL225939A (pt)
IT (1) IT1402749B1 (pt)
MX (1) MX341300B (pt)
PL (1) PL2632475T3 (pt)
PT (1) PT2632475T (pt)
RU (1) RU2606851C2 (pt)
SG (1) SG189536A1 (pt)
SI (1) SI2632475T1 (pt)
WO (1) WO2012055774A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016020855A1 (en) * 2014-08-08 2016-02-11 Rottapharm Biotech S.R.L. Purified grape seeds extracts, production and use thereof for the treatment of central and peripheric human diseases
KR101649450B1 (ko) * 2015-08-19 2016-08-18 이상철 피부 상처 치료조성물
ITUB20160058A1 (it) * 2016-01-19 2017-07-19 Farm S R L C U S Composizione di un preparato per il trattamento delle punture di insetto con attivita’ vasocostrittiva, lenitiva, disinfiammante e disarrossante
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
WO2018152758A1 (zh) * 2017-02-24 2018-08-30 拉芳家化股份有限公司 一种抗炎乳液
RU2704976C2 (ru) * 2017-05-10 2019-11-01 Общество с ограниченной ответственностью "Трейдсервис" Флеботропная комбинированная фармацевтическая композиция
JP7286131B2 (ja) * 2018-11-15 2023-06-05 学校法人順天堂 糖尿病性潰瘍の治癒促進剤
JP6749383B2 (ja) * 2018-11-20 2020-09-02 丸善製薬株式会社 Ｔｉｅ２活性化剤及び血管の成熟化剤、並びにＴｉｅ２活性化用経口組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
US20020127256A1 (en) * 2001-03-01 2002-09-12 Howard Murad Compositions and methods for treating dermatological disorders
ITMI20042414A1 (it) 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
WO2007143631A2 (en) * 2006-06-02 2007-12-13 Interhealth Nutraceuticals, Inc. Nutraceutical treatments for diabetic and non-diabetic wound healing
EP1882473A1 (en) * 2006-07-28 2008-01-30 Indena S.P.A. Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs
JP2008266215A (ja) * 2007-04-20 2008-11-06 Suntory Ltd 虚血後血管新生促進剤および血流改善剤
EP2344173A1 (en) * 2008-10-21 2011-07-20 Naturveda New synergic association for the treatment of deep skin or mucosa injuries
EP2179739A1 (en) * 2008-10-23 2010-04-28 Matteo Tutino Compositions comprising vitamins

Also Published As

Publication number Publication date
EP2632475B1 (en) 2016-09-14
AR083594A1 (es) 2013-03-06
PL2632475T3 (pl) 2017-06-30
RU2606851C2 (ru) 2017-01-10
EP2632475A1 (en) 2013-09-04
IL225939A (en) 2017-06-29
DK2632475T3 (da) 2017-01-02
AU2011322734B2 (en) 2015-05-14
CA2816185A1 (en) 2012-05-03
JP2013540788A (ja) 2013-11-07
IT1402749B1 (it) 2013-09-18
ES2606141T3 (es) 2017-03-22
KR20140000231A (ko) 2014-01-02
AU2011322734A1 (en) 2013-04-18
HUE032121T2 (en) 2017-08-28
RU2013124384A (ru) 2014-12-10
PT2632475T (pt) 2016-12-09
MX2013004740A (es) 2013-06-05
WO2012055774A1 (en) 2012-05-03
US20130236575A1 (en) 2013-09-12
SI2632475T1 (sl) 2016-11-30
JP6060084B2 (ja) 2017-01-11
IL225939A0 (en) 2013-06-27
ITMI20102009A1 (it) 2012-04-29
SG189536A1 (en) 2013-05-31
CA2816185C (en) 2020-05-12
CN103189066A (zh) 2013-07-03
KR101861347B1 (ko) 2018-05-28
US9770475B2 (en) 2017-09-26
MX341300B (es) 2016-08-11

Similar Documents

Publication Publication Date Title
BR112013010325A2 (pt) composições para o tratamento de úlceras periféricas de várias origens
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
ECSP12012310A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
BR112014018421A8 (pt) Composições antimicrobianas compreendendo dgla, 15-ohepa e/ou 15-hetre e métodos de uso das mesmas
BRPI1012219C1 (pt) produto, substrato, composição farmacêutica, usos de um produto, e de um peptídeo antimicrobiano, métodos para prevenir formação de biofilme em um ambiente, para tratar uma infecção microbiana por profilaxia ou terapia, e para tratar ou prevenir formação de biofilme em um ambiente, e, uso de uma cisteamina
DOP2011000285A (es) 2-acetamido-5-aril-1, 2, 4-triazolonas sustituidas y su uso
CO6511249A2 (es) Composiciones que comprenden tramadol y celecoxib en el tratamiento del dolor
BRPI0915439B8 (pt) composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição
BR112014024672A8 (pt) Composições farmacêuticas para terapia de combinação
BR112012018170B8 (pt) agente antimicrobiano para redução, inibição ou tratamento do crescimento microbiano, infecções microbianas, doenças inflamatórias, doenças ou condições virais resultantes de ou associadas aos mesmos
BR112015007878A2 (pt) composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos
ECSP10010494A (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
CO6710913A2 (es) Uso de ácido lipasa lisosomal para tratar la deficiencia de ácido lipasa lisosomal en pacientes
MX2010004613A (es) Composicion topica.
BR112016000350A8 (pt) métodos de tratamento de lesões inflamatórias da rosácea e usos de uma composição farmacêutica
CO6710926A2 (es) Compuestos de n-heteroarilo
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
UY32236A (es) Compuestos de arilo sustituidos y su uso
WO2014023895A3 (fr) Inhibition de l'adhesion de micro-organismes pathogenes par un sucrose stearate et/ou de sorbitan dans le traitement cosmetique de l'atopie cutanee
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
CU24390B1 (es) Piperidinil-tetrahidroquinolinas sustituidas
BR112014030534A2 (pt) composições de galacto-ramnogalacturonato para o tratamento de doenças associadas com óxido nítrico sintase induzível elevada
BR112014005398A2 (pt) peptídeo que inibe a atividade de metaloproteinases de matriz e uso do mesmo
BR112012024887A2 (pt) grânulos de quitosana, preenchedor, processo para preparar os grânulos de quitosana, kit e disposto de injeção
BR112012011017A2 (pt) processos e composições para tratamento rápido de otite externa

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]